Monthly News Roundup - March 2019

Mayzent First Oral Treatment Approved for Active Secondary Progressive MS
In March the U.S. Food and Drug Administration (FDA) approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), which includes...

Source: Drugs.com - Pharma News - March 31, 2019 Category: Pharmaceuticals Source Type: news